Blog September 14, 2022
Attorneys Daniel Tishman and Joshua Rosefelt Author "ITC Year in Review" Article in IPWatchdog
- Person title
The opinions expressed are those of the authors on the date noted above and do not necessarily reflect the views of Fish & Richardson P.C., any other of its lawyers, its clients, or any of its or their respective affiliates. This post is for general information purposes only and is not intended to be and should not be taken as legal advice. No attorney-client relationship is formed.
Article August 25, 2022
Fish Principal Daniel Tishman and Associate April Park Author IP Litigator Article "Two ITC Investigations Highlight Different Avenues for Early Disposition"...
Blog June 13, 2022
ITC Monthly Wrap-Up: May 2022 — Two Investigations Highlight Different Avenues for Early Disposition
Blog April 5, 2022
ITC Monthly Wrap-Up: March 2022
Article January 5, 2022
Fish Principals Author Intellectual Property & Technology Law Journal Article, "Strategic IP Considerations of Batteries and Energy Storage Solutions"
Article December 13, 2021
Fish Principals Author Article "Powering up" for Intellectual Property Magazine
Blog October 5, 2021
ITC Monthly Wrap-Up: September 2021
Article September 22, 2021
Fish Attorneys Author Law360 Article, "Navigating Bar To Patentability In 3rd-Party Secret Sales"
Article September 1, 2021
White Paper | Strategic IP Considerations of Batteries and Energy Storage Solutions
Blog July 24, 2015
PTAB's Construction Must Be "Reasonable" In Light of All Intrinsic Evidence, PTAB May Require Patentee to Show Amended Claims Are Patentable Over All Prior...
Blog December 4, 2023
Amended FRE 702 on Expert Testimony Effective December 1, 2023
Blog December 1, 2023
ITC Monthly Wrap-Up: November 2023
Blog November 27, 2023
Minnesota Patent Litigation Wrap-Up: Q3 2023
Blog November 15, 2023
ITC Monthly Wrap-Up: October 2023
Blog November 9, 2023
Legal Alert: FTC Challenges More Than 100 Patents as Improperly Listed in Orange Book
Blog November 3, 2023
District of Delaware Finds Allergan Patents Invalid for Lack of Written Description and Obviousness-Type Double Patenting in Allergan v. MSN Labs
Blog October 31, 2023
Texas Patent Litigation Monthly Wrap-Up: October 2023
Blog October 30, 2023
District of Delaware Finds Non-Orange Book-Listed Patents Subject to the Same Pleading Standard as Listed Patents in ANDA Infringement Suit
Blog October 11, 2023
ITC Monthly Wrap-Up: September 2023
Blog September 25, 2023
Federal Circuit Evaluates Enablement for Antibody Claims for the First Time Since Amgen v. Sanofi in Baxalta Inc. et al. v. Genentech, Inc.